RAP-001
Preclinical complete → moving to human trialsRapamycin + SMER28
Synergistic mTOR inhibition and autophagy enhancement; data in worms, flies, and mice.
Raptor Co ($RAPTOR) uses DeSci to accelerate healthspan-enhancing and life-extending therapies across DTC and prescription pathways.
Accelerating longevity science through decentralized collaboration
Rapamycin + SMER28
Synergistic mTOR inhibition and autophagy enhancement; data in worms, flies, and mice.
Rapamycin + Metformin + Rifampicin
Pre-launch on Pump.Science. Classic longevity trifecta advancing toward human study.
GlyNAC + Taurine + Urolithin A + Ca-AKG
Pre-launch on Pump.Science. Multi-pathway mitochondrial + nutrient-sensing enhancement (DTC first; clinical validation planned).
(Stealth)
Next-gen peptide or gene therapy (details TBA).
(Stealth)
AI-discovered small molecule (discovery-stage).
Owner-aligned, transparent-by-default. The following links are placeholders you can wire to IPFS/Arweave or a private data stack.
Raptor is the first onchain longevity biotech company launched on Pump.Science. Our aim is to use Decentralized Science (DeSci) and AI to accelerate healthspan-enhancing and life-extending therapies and products (both Consumer and Prescription therapies).
$RAPTOR operates as an ownership coin inspired by MetaDAO mechanics: tokenized participation, transparent milestones, and onchain governance.
CEO
@ryanbethencourtChairman
@eperlsteCSO
@andreb1o16